`BIB_356`

INTerpath-001 Phase III FULLY ENROLLED — Moderna/Merck announcement 20 January 2026.

Evidence grade: B
Tier: 1 (sponsor announcement via industry trade press)
Cited by tasks: 17, 18, 19a
Identifiers: —

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_356/findings.md (research corpus). This page is a short context summary — not individualised medical advice.